Key result
In a rat model of CHF, inhaled milrinone selectively dilated pulmonary blood vessels and significantly reduced lung edema without systemic hemodynamic compromise.
Why the study?
Does inhaled milrinone selectively improve pulmonary hemodynamics and reduce lung edema compared to intravenous milrinone in a rat model of congestive heart failure?
Does inhaled milrinone selectively improve pulmonary hemodynamics and reduce lung edema compared to intravenous milrinone in a rat model of congestive heart failure?
Inhaled milrinone selectively reduces pulmonary artery pressure and lung edema without causing systemic hypotension in a rat model of heart failure, suggesting a potential targeted therapy for pulmonary venous hypertension.
No takes yet. Share an insight, caveat, or question.
May warrant investigation as selective pulmonary vasodilator in heart failure; leaves open translation to human trials.
Hentschel et al. (2007) studied Congestive heart failure with pulmonary hypertension. Milrinone vs. 0.9% NaCl and sham-operated rats was evaluated on Pulmonary and systemic hemodynamics and lung water content. In a rat model of CHF, inhaled milrinone selectively dilated pulmonary blood vessels and significantly reduced lung edema without systemic hemodynamic compromise.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: